Do cross-reactive antibodies cause neuropathology in COVID-19?

J Kreye, SM Reincke, H Prüss - Nature Reviews Immunology, 2020 - nature.com
Neurological symptoms are seen in patients with COVID-19 and can persist or re-emerge
after clearance of SARS-CoV-2. Recent findings suggest that antibodies to SARS-CoV-2 can …

[HTML][HTML] Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement

E Song, CM Bartley, RD Chow, TT Ngo, R Jiang… - bioRxiv, 2020 - ncbi.nlm.nih.gov
One third of COVID-19 patients develop significant neurological symptoms, yet SARS-CoV-2
is rarely detected in central nervous system (CNS) tissue, suggesting a potential role for …

Clinical course of a patient with radiographically described acute necrotizing encephalopathy

P Bansal, EK Fory, S Malik, AB Memon - Radiology, 2020 - pubs.rsna.org
We write in reference to a reported case of acute necrotizing encephalopathy (ANE)
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

[HTML][HTML] COVID-19-Associated Encephalitis: Systematic Review of Case ReportsFindings on Cytokine-Immune-Mediated Inflammation as an Underlying Mechanism

YM Siahaan, V Puspitasari, AR Pangestu - 2020 - europepmc.org
Background: Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
primarily attacks the respiratory system resulting to a disease called coronavirus disease 19 …

[PDF][PDF] Encefalite Hemisférica Associada ao SARS-CoV-2

MCCS de Amorim, KO Couto… - REVISTA …, 2020 - hospitalsantaizabel.org.br
A nova síndrome respiratória aguda grave causada pelo novo coronavírus (SARS-CoV-2)
surgiu em Wuhan, China, e rapidamente se espalhou pelo mundo. Embora a apresentação …